The Central European Journal of Public Health, ISSN 1210-7778 and E-ISSN 1803-1048, is a vital academic forum published by the NATIONAL INSTITUTE OF PUBLIC HEALTH, Czech Republic. With its comprehensive coverage of contemporary issues in public health and medicine since its inception in 1993, this journal aims to bridge the gap between research and practice, fostering a deeper understanding of health dynamics within Central Europe and beyond. As a Q3 ranked journal in both the fields of Medicine (miscellaneous) and Public Health, Environmental and Occupational Health as per 2023 metrics, it provides an accessible platform for innovative studies, policy analyses, and reviews that contribute to the global discourse on public health challenges. Though primarily based in the Czech Republic, it welcomes contributions from a worldwide audience, enhancing its scope and impact. Researchers, practitioners, and students will find invaluable insights that not only enrich academic scholarship but also inform effective public health interventions.

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Lancet Regional Health-Western Pacific is a premier academic journal published by Elsevier, focusing on the diverse and dynamic field of health in the Western Pacific region. With an impressive Q1 ranking across several vital categories such as Geriatrics and Gerontology, Health Policy, Infectious Diseases, and Public Health, this journal is positioned at the forefront of health research and policy development. The journal aims to provide a platform for innovative research, reviews, and opinion pieces that lead to improved health outcomes and influence health policy across this geographically and culturally rich area. Offering open access to its content, Lancet Regional Health-Western Pacific ensures that the latest findings are readily available to researchers, professionals, and policymakers alike, ultimately contributing to the global discourse on health issues. As it continually strives to maintain rigorous publication standards, the journal serves as a crucial resource in promoting evidence-based practices and driving advancements in public health.

Journal of Preventive Medicine & Public Health is a premier peer-reviewed open-access journal published by the Korean Society for Preventive Medicine, dedicated to advancing the fields of preventive medicine and public health. Established in 1968, this journal has carved out a significant niche in the academic community, reflected in its prestigious Q1 ranking in both Medicine (miscellaneous) and Public Health, Environmental, and Occupational Health as of 2023. With a focus on disseminating high-quality research, the journal serves as an essential platform for researchers, professionals, and students to share innovative findings and discuss contemporary challenges in health prevention strategies. The journal maintains a strong commitment to accessibility, offering open access to its content since inception, ensuring that critical research is readily available to the global community. The Journal of Preventive Medicine & Public Health not only contributes to the scientific discourse but also plays a pivotal role in shaping public health policies, making it an invaluable resource for anyone invested in the health sciences.

PLOS Medicine, published by the Public Library of Science, stands as a preeminent open-access journal dedicated to advancing global health through impactful research and discourse. Established in 2004, it has maintained its open-access nature, ensuring that groundbreaking studies in medicine, biochemistry, biotechnology, cell biology, and molecular biology remain accessible to a global audience. With an impressive ranking of 14 out of 636 in General Medicine and a remarkable 97th percentile according to Scopus, PLOS Medicine is recognized for its influential contributions to the medical community. The journal not only aims to disseminate high-quality research but also to foster collaboration across disciplines to improve health outcomes worldwide. Researchers, professionals, and students alike can benefit from the wealth of knowledge and innovations presented in this leading journal, making it an essential resource in the field of medical science.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.

ANNALS OF EPIDEMIOLOGY, published by Elsevier Science Inc, stands as a leading journal in the field of epidemiology, with an impressive impact factor that reflects its significant contribution to public health research. With an ISSN of 1047-2797 and an E-ISSN of 1873-2585, the journal has been at the forefront of disseminating high-quality, peer-reviewed research since its inception in 1990. It is consistently ranked in the first quartile (Q1) for epidemiology in 2023, occupying the 29th position out of 148 in the Scopus Medicine category, with a percentage ranking in the 80th percentile. The journal aims to provide a comprehensive platform for the interdisciplinary exchange of pioneering epidemiological studies, exploring diverse health issues and their societal impacts. Researchers, professionals, and students alike will find valuable insights and innovative methodologies within its pages, making it an essential resource for anyone engaged in the study and application of epidemiology. Its headquarters located in the United States (STE 800, 230 Park Ave, New York, NY 10169) further reinforces its influence in the academic community.

The Lancet Public Health is a leading journal in the field of public health, published by Elsevier since 2016. With its prominent Q1 quartile ranking in Public Health, Environmental and Occupational Health according to Scopus for 2023, and an impressive percentile ranking of 99th, the journal has established itself as a vital resource for researchers, professionals, and students committed to advancing public health knowledge and practices. Operating under an Open Access model, this journal ensures that groundbreaking research is readily accessible to all, promoting global collaboration and knowledge sharing. The scope of The Lancet Public Health encompasses diverse aspects of health, including the social determinants of health, epidemiology, health policy, and preventive medicine, making it a cornerstone for addressing contemporary public health challenges. Located in the heart of the United Kingdom, it aims to influence health policies and practices worldwide, showcasing transformative research and fostering vibrant discussions within the field.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.